Literature DB >> 12193561

Potentiation of glucocorticoid receptor transcriptional activity by sumoylation.

Yves Le Drean1, Nathalie Mincheneau, Pascale Le Goff, Denis Michel.   

Abstract

The glucocorticoid receptor (GR) is a transcription factor, subject to several types of posttranslational modifications including phosphorylation and ubiquitination. We showed that the GR is covalently modified by the small ubiquitin-related modifier-1 (SUMO-1) peptide in mammalian cells. We demonstrated that GR sumoylation is not dependent on the presence of the ligand and regulates the stability of the protein as well as its transcriptional activity. SUMO-1 overexpression induces dramatic GR degradation, abolished by proteasome inhibition. We also found that SUMO-1 stimulates the transactivation capacity of GRs to an extent largely exceeding those observed so far for other sumoylated transcription factors. Overexpression of SUMO-1 specifically enhances the ligand-induced transactivation of GR up to 8-fold. However, this hyperactivation occurs only in the context of a synergy between multiple molecules of GRs. It requires more than one receptor DNA-binding site in promoter and becomes more prominent as the number of sites increases. Interestingly, these observations may be related to the transcriptional properties of the synergy control region of GRs, which precisely contains two evolutionary conserved sumoylation sites. We propose a model in which SUMO-1 regulates the synergy control function of GR and serves as a unique signal for activation and destruction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193561     DOI: 10.1210/en.2002-220135

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  44 in total

1.  Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling.

Authors:  Amy Jo Galliher-Beckley; Jason Grant Williams; John Anthony Cidlowski
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.

Authors:  Sam Holmstrom; Mary E Van Antwerp; Jorge A Iñiguez-Lluhi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

Review 3.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 4.  SUMO wrestling with type 1 diabetes.

Authors:  Manyu Li; Dehuang Guo; Carlos M Isales; Decio L Eizirik; Mark Atkinson; Jin-Xiong She; Cong-Yi Wang
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

5.  Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

Authors:  Hany Abdel-Hafiz; Michelle L Dudevoir; Kathryn B Horwitz
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

Review 6.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

7.  Sumoylation modulates the assembly and activity of the pre-mRNA 3' processing complex.

Authors:  Vasupradha Vethantham; Nishta Rao; James L Manley
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

Review 8.  Corticosteroids: Mechanisms of Action in Health and Disease.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Rheum Dis Clin North Am       Date:  2016-02       Impact factor: 2.670

9.  Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation.

Authors:  Raj Kumar; William J Calhoun
Journal:  Biologics       Date:  2008-12

10.  Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries.

Authors:  Stefano Cagnin; Michele Biscuola; Cristina Patuzzo; Elisabetta Trabetti; Alessandra Pasquali; Paolo Laveder; Giuseppe Faggian; Mauro Iafrancesco; Alessandro Mazzucco; Pier Franco Pignatti; Gerolamo Lanfranchi
Journal:  BMC Genomics       Date:  2009-01-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.